Data: Company filings; Chart: Sara Wise/Axios
The four main drug companies making COVID-19 vaccines have sold a combined $18.6 billion worth of the shots in the first half of 2021, and sales are expected to reach a combined $60 billion by the end of the year.
The big picture: Even though the U.S. represents less than 5% of the global population, the U.S. market makes up 41% of the vaccine sales.
